In the biopharma sector today, it's another case of some winning and some losing. $Novavax(NVAX.US) surged dramatically, turning its revenue miss into a meme. I, who missed the boat, got another harsh lesson. $Moderna(MRNA.US) rose steadily, truly the endurance king, making me regret not getting in early every time, yet I dare not go heavy.
$Vor BioPharma(VOR.US) is thrilling with its small-cap volatility, just watching it makes my heart race. I want to catch the falling knife but fear getting cut. Meanwhile, $Curanex Pharmaceuticals(CURX.US) soared after-hours, leaving me a bit stunned... Sigh, in a nutshell, in pharma, the bold win fast, but naive investors get harvested just as quickly. I'll keep watching for now.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
